| Date Filed | Type | Description |
| 10/11/2023 |
8-K/A
| Quarterly results |
| 10/11/2023 |
8-K
| Quarterly results |
| 09/28/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
8-K
| Quarterly results |
| 05/10/2023 |
8-K
| Investor presentation |
| 04/13/2023 |
8-K
| Quarterly results |
| 02/24/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 01/31/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 01/06/2023 |
8-K
| Investor presentation |
| 12/30/2022 |
8-K
| Quarterly results |
| 12/23/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 10/07/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/16/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 07/22/2022 |
8-K
| Quarterly results |
| 01/20/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"[Certain identified information has been excluded from the exhibit because it is both not material and would be competitively harmful if publicly disclosed.] Non-Exclusive Distribution and Supply Agreement This Non-Exclusive Distribution and Supply Agreement is entered into as of January 19, 2022 by and between Sonoma Pharmaceuticals, Inc., a Delaware corporation having a place of business at 645 Molly Ln, Suite 150, Woodstock, GA 30189 and Salus Medical, LLC a Limited Liability Company, having a place of business at 2202 W Lone Cactus Dr #15, Phoenix, AZ 85027 . Whereas, Supplier manufactures certain products based on the Proprietary Rights and subject to the Label Claims as approved by the Government Authorities, which it is willing to supply to Distributor on the terms and subject to th...",
"[Certain identified information has been excluded from the exhibit because it is both not material and would be competitively harmful if publicly disclosed.]" |
|
| 01/14/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/06/2022 |
8-K
| Investor presentation |
| 11/09/2021 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 09/21/2021 |
8-K
| Quarterly results |
| 09/03/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/02/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/30/2021 |
8-K
| Quarterly results |
| 07/20/2021 |
8-K
| Quarterly results |
| 07/09/2021 |
8-K
| Quarterly results |
| 07/06/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/31/2021 |
8-K
| Quarterly results |
| 03/04/2021 |
8-K
| Quarterly results |
| 01/11/2021 |
8-K
| Quarterly results |
| 01/08/2021 |
8-K
| Quarterly results |
| 12/17/2020 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 12/10/2020 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 11/17/2020 |
8-K
| Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review |
| 09/18/2020 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 09/11/2020 |
8-K
| Quarterly results |
|